{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:30:33Z","timestamp":1780471833572,"version":"3.54.1"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Acute ST-elevation myocardial infarction (STEMI) is a frequent and serious presentation of acute coronary syndrome. The STOP-SCA+ study aimed to (i) describe 1-year compliance to secondary prevention cardiac tri-therapy and (ii) identify factors associated with negative outcomes 1 year after STEMI, particularly the impact of compliance and rehabilitation care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients who were &amp;gt;18 years old and hospitalized for STEMI in five interventional cardiac centers with the same cardiac registry in one French region (2.5 million inhabitants), between 2014 and 2018, were included. After a probabilistic matching with the National Health Insurance database [Syst\u00e8me National des Donn\u00e9es de Sant\u00e9 (SNDS), 96% matching], compliance for cardiac tri-therapy was studied: aspirin, P2Y12 inhibitor, and statin. Factors associated with poor outcomes (ischemic complications, death) were analyzed using Cox modeling and those for compliance by logistic regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 3,768 patients were included, of whom 84% underwent primary percutaneous coronary intervention. At 1 year, 3,362 had at least one tri-therapy delivery (89.2%), of whom 53% were compliant, and 2,478 patients went to cardiac rehabilitation (65.8%). Death occurred in 130 patients and\/or ischemic complications in 194 (total of poor outcomes 8.0%). Compliance was not associated with complications over the year [HR 1.16 (0.86\u20131.57)], while the absence of cardiac rehabilitation [2.31 (1.73\u20133.08)] was associated, as well as female sex 1.54 (1.08\u20132.19), renal impairment [2.87 (1.49\u20135.53)], initial STEMI clinical presentation [pejorative Killip 2.04 (1.19\u20133.50)], and LVEF &amp;lt;40% at discharge [2.22 (1.65\u20132.99)]. Additionally, cardiac rehabilitation was associated with compliance [OR 1.55 (1.34\u20131.79)].<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Pejorative outcomes 1 year after a STEMI represented 8% of cases, mainly related to patient features, the initial clinical presentation, and the absence of access to rehabilitation. Compliance part in patient health outcomes will need further modeling to accurately study its impact. Matching clinical and medico-administrative databases proved to be relevant for assessing outcomes at a large scale.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2025.1484401","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T01:21:11Z","timestamp":1749691271000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of cardiac rehabilitation and treatment compliance after ST-segment elevation myocardial infarction (STEMI) in France, the STOP SCA+ study"],"prefix":"10.3389","volume":"12","author":[{"given":"Emeline","family":"Laurent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucile","family":"Godillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc-Florent","family":"Tassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Marcollet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phan","family":"Chassaing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Decomis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Bezin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Laure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Angoulvant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9goire","family":"Range","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Grammatico-Guillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"key":"B1","article-title":"L\u2019\u00e9tat de sant\u00e9 de la population en France Rapport 2017\u2014Principales causes de d\u00e9c\u00e8s et de mortalit\u00e9","year":"2017"},{"key":"B2","article-title":"Infarctus du myocarde","year":""},{"key":"B3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.respe.2018.01.135","article-title":"The CRAC cohort model: a computerized low cost registry of interventional cardiology with daily update and long-term follow-up","volume":"66","author":"Rang\u00e9","year":"2018","journal-title":"Rev Epidemiol Sante Publique"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European society of cardiology (ESC)","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"B5","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1001\/jama.2022.0358","article-title":"Diagnosis and treatment of acute coronary syndromes: a review","volume":"327","author":"Bhatt","year":"2022","journal-title":"JAMA"},{"key":"B6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.amjcard.2023.01.003","article-title":"Extending our knowledge of lifetime outcomes after ST-elevation myocardial infarction","volume":"191","author":"Widmer","year":"2023","journal-title":"Am J Cardiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.acvd.2018.04.008","article-title":"Factors associated with delay in transfer of patients with ST-segment elevation myocardial infarction from first medical contact to catheterization laboratory: lessons from CRAC, a French prospective multicentre registry","volume":"112","author":"Rang\u00e9","year":"2019","journal-title":"Arch Cardiovasc Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.ancard.2018.09.016","article-title":"Non-ST elevation acute coronary syndrome: cRAC register experience","volume":"67","author":"Hakim","year":"2018","journal-title":"Ann Cardiol Angeiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/ejcts\/ezy289","article-title":"2018 ESC\/EACTS guidelines on myocardial revascularization","volume":"55","author":"Sousa-Uva","year":"2019","journal-title":"Eur J Cardiothorac Surg"},{"key":"B10","first-page":"524","article-title":"The French registry of acute ST elevation or non-ST-elevation myocardial infarction (FAST-MI): study design and baseline characteristics","volume":"100","author":"Cambou","year":"2007","journal-title":"Arch Mal Coeur Vaiss"},{"key":"B11","doi-asserted-by":"publisher","first-page":"P77","DOI":"10.4244\/EIJV8SPA13","article-title":"Stent for life in France","volume":"8","author":"Gilard","year":"2012","journal-title":"EuroIntervention"},{"key":"B12","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.acvd.2009.08.004","article-title":"Door-to-balloon delays before primary angioplasty in the Regional Acute Myocardial Infarction Registry of Brittany. An analysis of the observatoire r\u00e9gional Breton sur l\u2019Infarctus du myocarde (ORBI)","volume":"102","author":"Leurent","year":"2009","journal-title":"Arch Cardiovasc Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00059-015-4369-1","article-title":"ESC Guidelines 2015\u202f: non-ST-elevation acute coronary syndrome","author":"Jobs","year":"2015","journal-title":"Herz"},{"key":"B14","doi-asserted-by":"publisher","first-page":"17588359221113264","DOI":"10.1177\/17588359221113264","article-title":"Time interval from last visit to imaging diagnosis influences outcome in pancreatic adenocarcinoma: a regional population-based study on linked medico-administrative and clinical data","volume":"14","author":"Balzano","year":"2022","journal-title":"Ther Adv Med Oncol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"00157","DOI":"10.1183\/23120541.00157-2022","article-title":"1-year mortality in lung cancer in France according to key timepoints of care pathways","volume":"8","author":"Rivi\u00e8re","year":"2022","journal-title":"ERJ Open Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"102126","DOI":"10.1016\/j.respe.2023.102126","article-title":"Regulation of medical research in France: striking the balance between requirements and complexity","volume":"71","author":"Boyer","year":"2023","journal-title":"Rev Epidemiol Sante Publique"},{"key":"B17","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/pds.1230","article-title":"Methods for evaluation of medication adherence and persistence using automated databases","volume":"15","author":"Andrade","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"B18","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/fcp.12756","article-title":"Antihypertensive and lipid-lowering drugs usage after primary stroke in a large representative sample of the French population","volume":"36","author":"Perrier","year":"2022","journal-title":"Fundam Clin Pharmacol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1161\/CIRCULATIONAHA.113.005874","article-title":"Five-year survival in patients with ST-segment-elevation myocardial infarction according to modalities of reperfusion therapy: the French registry on acute ST-elevation and non-ST-elevation myocardial infarction (FAST-MI) 2005 cohort","volume":"129","author":"Danchin","year":"2014","journal-title":"Circulation"},{"key":"B20","volume-title":"Indicateurs \u00e9cologiques Synth\u00e9tiques du Niveau Socio-\u00e9conomique pour la Recherche en Sant\u00e9","author":"Ghosn","year":"2018"},{"key":"B21","doi-asserted-by":"publisher","first-page":"B16","DOI":"10.1093\/eurheartjsupp\/suac003","article-title":"Long-term follow-up in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention","volume":"24","author":"Klancik","year":"2022","journal-title":"Eur Heart J Suppl"},{"key":"B22","doi-asserted-by":"publisher","first-page":"303","DOI":"10.4244\/EIJY15M10_07","article-title":"Outcome after percutaneous coronary intervention for different indications: long-term results from the Swedish coronary angiography and angioplasty registry (SCAAR)","volume":"12","author":"Fokkema","year":"2016","journal-title":"EuroIntervention"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1016\/j.jacc.2014.08.037","article-title":"Short- and long-term cause of death in patients treated with primary PCI for STEMI","volume":"64","author":"Pedersen","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.acvd.2019.04.002","article-title":"Outcome associated with prescription of cardiac rehabilitation according to predicted risk after acute myocardial infarction: insights from the FAST-MI registries","volume":"112","author":"Puymirat","year":"2019","journal-title":"Arch Cardiovasc Dis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.amjcard.2013.03.030","article-title":"Study design and baseline characteristics of the national observational study of diagnostic and interventional cardiac catheterization by the French Society of Cardiology","volume":"112","author":"Puymirat","year":"2013","journal-title":"Am J Cardiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1093\/eurheartj\/ehy417","article-title":"Impact of ambulatory cardiac rehabilitation on cardiovascular outcomes: a long-term follow-up study","volume":"40","author":"Doimo","year":"2019","journal-title":"Eur Heart J"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.3390\/ijerph20043182","article-title":"Causal model building in the context of cardiac rehabilitation: a systematic review","volume":"20","author":"Akbari","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"B30","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.acvd.2023.12.008","article-title":"Temporal trends in admission for cardiac rehabilitation after an acute coronary syndrome in France from 2009 to 2021: persistent sex, age and social disparities","volume":"117","author":"Grave","year":"2024","journal-title":"Arch Cardiovasc Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/aje\/kwv254","article-title":"Using big data to emulate a target trial when a randomized trial is not available","volume":"183","author":"Hern\u00e1n","year":"2016","journal-title":"Am J Epidemiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.jclinepi.2005.07.004","article-title":"A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods","volume":"59","author":"St\u00fcrmer","year":"2006","journal-title":"J Clin Epidemiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e497","DOI":"10.1093\/cid\/ciaa169","article-title":"Comparing propensity score methods versus traditional regression analysis for the evaluation of observational data: a case study evaluating the treatment of gram-negative bloodstream infections","volume":"71","author":"Amoah","year":"2020","journal-title":"Clin Infect Dis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/fcp.12143","article-title":"Choice of ICD-10 codes for the identification of acute coronary syndrome in the French hospitalization database","volume":"29","author":"Bezin","year":"2015","journal-title":"Fundam Clin Pharmacol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1001\/2012.jama.11348","article-title":"Association of changes in clinical characteristics and management with improvement in survival among patients with ST-elevation myocardial infarction","volume":"308","author":"Puymirat","year":"2012","journal-title":"JAMA"}],"updated-by":[{"DOI":"10.3389\/fcvm.2025.1656799","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000}}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1484401\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T10:26:12Z","timestamp":1757586372000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1484401\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,12]]},"references-count":35,"alternative-id":["10.3389\/fcvm.2025.1484401"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1484401","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.10.05.23296631","asserted-by":"object"}]},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,12]]},"article-number":"1484401"}}